Latest data from September 24, 2021
Number of Health Center respondents = 46 (73% of all Health Centers)
Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patients Tested
| Metrics | Value |
|---|---|
| Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 | 36,120 |
| Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) | 74.40% |
| Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 | 2,051 |
| Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) | 56.41% |
Patients by Race and Ethnicity
| Race/Ethnicity | Patients Tested, Virus Detection (PCR, antigen)2 | Patients Tested Positive, Virus Detection (PCR, antigen)2 |
|---|---|---|
| White, Non-Hispanic/Latino Patients | 17.79% | 31.69% |
| White, Hispanic/Latino Patients | 6.64% | 7.12% |
| Black/African American, Non-Hispanic/Latino Patients | 20.48% | 14.97% |
| Black/African American, Hispanic/Latino Patients | 2.29% | 1.51% |
| Asian Patients3 | 3.78% | 2.83% |
| American Indian/Alaska Native Patients3 | 0.31% | 0.34% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.43% | 0.54% |
| Patients with More than one race3 | 2.21% | 1.56% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 15.55% | 12.14% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 8.50% | 4.83% |
| Unreported/Refused to Report Race and Ethnicity | 22.02% | 22.48% |
Patients Vaccinated
| Metrics | Value |
|---|---|
| COVID-19 Immunization Series Initiated | 12,192 |
| Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization | 92.40% |
| COVID-19 Immunization Series Completed | 22,420 |
| Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization | 96.66% |
| COVID-19 Immunization Series Additional | 381 |
| Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine | 65.29% |
Vaccinations by Race and Ethnicity
| Race/Ethnicity | Patient COVID-19 Immunization Series Initiated2 | Patient COVID-19 Immunization Series Completed2 | Patient COVID-19 Immunization Series Additional2 |
|---|---|---|---|
| White, Non-Hispanic/Latino Patients | 5.81% | 2.90% | 28.61% |
| White, Hispanic/Latino Patients | 9.01% | 5.79% | 4.72% |
| Black/African American, Non-Hispanic/Latino Patients | 24.42% | 13.22% | 17.59% |
| Black/African American, Hispanic/Latino Patients | 3.58% | 1.90% | 1.31% |
| Asian Patients3 | 1.80% | 0.93% | 4.72% |
| American Indian/Alaska Native Patients3 | 0.49% | 0.25% | 4.72% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.48% | 0.30% | 0.26% |
| Patients with More than one race3 | 6.65% | 46.81% | 0.79% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 24.17% | 14.65% | 19.69% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 4.36% | 2.46% | 4.72% |
| Unreported/Refused to Report Race and Ethnicity | 19.22% | 10.80% | 12.86% |
Testing Logistics
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)
| Metrics | Value |
|---|---|
| Less Than 1 Hour | 13.04% |
| 1 to 24 Hours | 23.91% |
| More Than 24 Hours | 60.87% |
| N/A | 2.17% |
Vaccine Logistics
Challenges in Deploying the COVID Vaccine
| Metrics | Value |
|---|---|
| Financial reimbursement for costs associated with vaccine administration | 13.04% |
| Staffing to administer the vaccine | 34.78% |
| Vaccine confidence | 47.83% |
| Vaccine storage capacity | 0.00% |
| Vaccine supply | 2.17% |
| Other | 6.52% |
| None | 23.91% |
Operations and Staff
| Metrics | Value |
|---|---|
| Health Center Weekly Visits Compared to Pre-COVID 19 Weekly Visits | 94.57% |
| Average Percent of Health Center Visits Conducted Virtually | 16.09% |
Mobile Vans, Pop-Up Clinics, and School-Based Sites
| Metrics | Value |
|---|---|
| Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics | 32.61% |
| Number of Mobile Van Sites | 10 |
| Number of Pop-up Clinics | 68 |
| Number of School-Based Vaccination Sites | 4 |
Monoclonal Antibody Therapy
Methods in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Direct provision of monoclonal antibody therapies | 6.52% |
| Refer patients to another organization that provides monoclonal antibody therapies | 34.78% |
| None | 58.70% |
Challenges in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Access to therapeutics | 13.04% |
| Patient awareness/education | 8.70% |
| Staffing capacity | 26.09% |
| Therapy administration/onsite logistics | 32.61% |
| Other | 6.52% |
| None | 41.30% |
1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
2 Percentages may not add to 100% due to rounding to the hundredths.
3 Includes Hispanic/Latino and Non-Hispanic/Latino.
